Newsroom

VENLO, Niederlande--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Markteinführung des QIAprep&amp Plasmodium Kits und zwei ergänzender Assays bekannt, die die Malariaforschung und -überwachung unterstützen sollen. Diese neue Lösung kombiniert die Probenvorbereitung und die quantitative PCR (qPCR) in einem einzigen Workflow und bietet so ein schnelles und leicht zugängliches Tool, um Malaria verursachende Parasiten in Blutproben nachzuweisen. Malaria...

VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to support malaria research and surveillance efforts. This new solution combines sample preparation and quantitative PCR (qPCR) into a single workflow, providing a rapid and accessible tool for detecting malaria-causing parasites from blood samples. Malaria remains one of the world’s most pressing public health cha...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing, with a rapidly developing presence in highly specialised and molecular clinical diagnostics testing and in-vitro diagnostics products, announces the successful closing of the acquisition of SYNLAB’s clinical diagnostics operations in Spain and the transfer of operations to Eurofins, which took place on 31 March 2025. SYNLAB’s clinical diagnostics operations in Spain...

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) ("FF", "Faraday Future", or the "Company"), a California-based global shared intelligent electric mobility ecosystem company, timely filed its 2024 Annual Report on Form 10-K before market open today, providing a comprehensive overview of its financial and operational performance. The report highlights the Company's key financial metrics, business operations and strategic initiatives. FF also just delivered th...

SAN ANTONIO--(BUSINESS WIRE)--Victory Capital closes its transaction with Amundi. Expense synergy target raised from $100 million to $110 million, $50 million achieved at closing....

HEIDELBERG, Germany--(BUSINESS WIRE)--SATO Europe GmbH announces the official launch of AEP Cloud, a powerful, cloud-based aPaaS1 solution designed to revolutionize labelling and identification processes within SATO’s strategic positioning as a provider of "Perfect and Unique Tagging.” With a robust set of features tailored for seamless implementation, AEP Cloud helps businesses simplify complex workflows, boost operational accuracy and achieve new levels of efficiency. Perfect and unique taggi...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the inclusion of a new dried blood spot extraction (DBS) kit as part of their industry-leading Simoa® assay kits at the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in Vienna, Austria. This new extraction kit enables researchers to measure low-concentration biomar...

OSLO, Norway--(BUSINESS WIRE)--Neat, the pioneering video technology company, today opens its new Neat Experience Center at its expanded Oslo headquarters. Connected to its existing headquarters space at Technopolis, the new 433 square meter space is designed to showcase the full breadth of Neat’s innovative portfolio in a welcoming and open office environment. The Oslo Neat Experience Center features five meeting rooms designed to highlight Neat’s devices in a variety of meeting space settings...

HANOVER, Germany--(BUSINESS WIRE)--Accenture is working with Schaeffler AG to reinvent industrial automation with physical AI and robotics....

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company’s board of directors (the “Board”) has decided to declare a special cash dividend of US$55.00 per common share (the “Dividend”). The Board expects to fund the Dividend from available cash resources of the Company and its subsidiaries, including prior distributions from Sinovac Life Sciences Co., Ltd. and other oper...